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Background: Diabetic nephropathy (DN) is one of the most serious microvascular complications of
diabetes and the leading cause of end-stage renal failure. However, the treatment of DN is still a problemKey Words:
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in the world. Inﬂammatory process plays a critical role in the development of DN. Therefore, anti-
inﬂammatory treatment of DN is worth exploring now and in the future.
Objective: The study aimed to evaluate the impact of ursolic acid (UA) on renal function in streptozo-
tocin-induced diabetes.
Methods: Rats with streptozotocin-induced diabetes were treated with UA for 16 weeks. After 16 weeks,
urine albumin excretion, serum creatinine, and blood urea nitrogen were measured. In addition, renal
oxidative stress level, nuclear factor kappa-B (NF-κB) activity, P-selectin expression, and kidney
histopathologic changes were evaluated.
Results: Sixteen weeks following streptozotocin injection, the rats produced signiﬁcant alteration in
renal function and increased oxidative stress, NF-κB activity, and P-selectin expression in the kidneys.
Interestingly, UA signiﬁcantly prevented biochemical and histopathologic changes in the kidneys
associated with diabetes. Compared with untreated diabetic rats, UA treatment lowered urine albumin
excretion, renal oxidative stress level, NF-κB activity, and P-selectin expression. Moreover, UA treatment
also improved renal histopathologic changes in rats with diabetes.
Conclusions: UA treatment exhibited a protective effect on kidneys in diabetic rats, implying that UA
could be a potential treatment for diabetic nephropathy.
& 2013. The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Diabetic nephropathy (DN), 1 of the most serious microvascular
complications of diabetes, is the leading cause of end-stage renal
failure. The pathologic changes of DN are characterized by early
glomerular hypertrophy and later glomerulosclerosis and tubulointer-
stitial ﬁbrosis, which is caused by the accumulation of extracellular
matrix components in the glomerular mesangium and tubulointer-
stitium. However, the intimate mechanisms leading to the develop-
ment and progression of renal injury in diabetes have not been fully
elucidated. Growing evidence demonstrates that the inﬂammatory
process plays a critical role in the development of DN.1–3 Different
inﬂammatory molecules, including chemokines, adhesion molecules,
and proinﬂammatory cytokines, may be critical factors involved in DN.
The ubiquitous transcription factor nuclear factor-κ-B (NF-κB)
is 1 of the cross-talk points of multiple signal transduction path-
ways that plays a key role in the regulation of transcription and ther Inc.
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ity, Donghu Rd 169, Wuhan,
.
Open access under CC BY-NC-ND liceexpression of many genes involved in inﬂammatory responses.4,5
An increase in the nuclear translocation of NF-κB and subsequently
coordinated expression of gene products may play an important
role in the pathogenesis of DN.6 Therefore, inhibition of NF-κB
activation may be beneﬁcial for the treatment of DN.
Ursolic acid (UA) is a pentacyclic triterpenoid found in many
herbs and spices like rosemary and thyme, but also in fruits,
including apples, cranberries, and blueberries. UA has been pri-
marily studied as an anticancer and anti-inﬂammatory compound,
a series of evidences indicated UA was a potent inhibitor of
NF-κB.7,8 In addition, dietary supplementation with UA was found
to improve glycemic control and lipid proﬁles, to decrease lipid
accumulation in the liver, and increase antioxidant enzyme activity
in rodent models of metabolic disease.9 Therefore, we sought to
clarify that UA prevents the progression of DN in a rat model.
Involvement of inﬂammatory mediators through the NF-κB path-
way in the pathologic effects was also analyzed.Materials and Methods
Animals and the model for diabetes
The animals used were male Wistar rats (weighing 160 [14] g).
Diabetes was induced according intraperitoneal injections ofnse.
Table
Laboratory determinations of control rats (Group C), untreated diabetic rats (Group
D), and diabetic rats treated with ursolic acid (Group D+UA) (n ¼ 6).
Determinant Group C Group D Group D+UA
Mean [SD]
Glucose (mmol/L) 4.8 [0.5] 18.3 [3.6]* 15.9 [3.6]*
Total cholesterol (mmol/L) 1.92 [0.18] 2.83 [0.15] 2.62 [0.27]
Triglycerides (mmol/L) 0.73 [0.07] 1.02 [0.17]* 0.97 [0.18]*
Serum creatinine (μmol/L) 61.73 [10.52] 86.33 [10.22] 69.80 [12.86]
Blood urea nitrogen (mmol/L) 5.22 [0.93] 7.23 [0.52] 6.81 [0.79]
Urine albumin excretion (μg/min) 22.33 [10.09] 68.96 [14.1]* 34.90 [8.19]†
nP o 0.05 versus group C.
†P o 0.05 versus group D.
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days later, STZ-treated rats in which blood glucose concentration
was o16.7 mmol/L were excluded from the experiment.
Design of the study
The animals were randomized into 3 groups: the control group,
untreated diabetic group, and UA-treated diabetic group. Control
group rats and untreated diabetic rats were fed standard rat chow
diets, UA-treated diabetic rats were given diets supplemented with
0.2% UA. Sixteen weeks later, all rats were put to death. The day
before anesthetizing, a 24-hour urine collected was done to
determine urine albumin excretion. During anesthetizing, blood
was taken by puncture of the right heart to determine blood
glucose and serum total cholesterol, triglyceride, creatinine, and
blood urea nitrogen levels. Both the kidneys were isolated; the left
kidney was deep frozen till further enzymatic analysis, whereas the
right kidney was stored in 10% formalin for histologic sectioning.
Laboratory determinations
Blood glucose was measured using a Bayer glucometer (Bayer
HealthCare Pharmaceuticals, Montville, NJ). Urine albumin was
measured by a competitive ELISA assay according to the manu-
facturer’s instruction (Exocell, Philadelphia, Pa). Serum total
cholesterol, triglyceride, creatinine, and urea nitrogen were deter-
mined with a Technicon RA-XT biochemical analyzer (Technicon
Corporation, Tarrytown, NY).
Measurement of 8-hydroxy-2’-deoxyguanosine (8-OhdG) levels by
immunohistochemistry
Immunostaining analysis of 8-OHdG was performed to evaluate
oxidative DNA injury of kidneys. The sections were incubated with
anti-8-OHdG mouse monoclonal antibody, probed with antimouse
immunoglobulin G antibody labeled with peroxidase. The sites of
peroxidase were visualized with diaminobenzidine.
Electrophoretic mobility shift assays (EMSA) for NF-κB activity
To determine NF-κB activation, we performed EMSA. The
speciﬁcity of binding was examined by competition with an
unlabeled oligonucleotide. For supershift assays, nuclear extracts
prepared from kidney tissue were analyzed by EMSA. The NF-κB
activation was assayed using an EMSA kit (Viagene Biotech,
Ningbo, China) according to the manufacturer’s protocol. The
consensus NF-κB oligonucleotides included in the kit were
5‘-AGT TGA GGG GAC TTT CCC AGG C-3’, The dried gels were
visualized and analyzed with Labworks 4.5 software (UVP Inc,
Upland, CA).
Reverse transcription-polymerase chain reaction for P-selectin mRNA
expression
Total RNA was extracted using Trizol (Invitrogen) according to
the manufacturer’s instructions. Three micrograms of total RNA
was used to prepare cDNA by Superscript II RNase H reverse
transcriptase (Life Technologies, Carlsbad, Calif). cDNA was ampli-
ﬁed by polymerase chain reaction using Taq DNA polymerase (MBI
Fermentas, Waltham, MA) and the following gene-speciﬁc primers
(synthesized by Shanghai Bioasia Biotechnology Co, Shanghai,
China): sense 5’– TCC AGT AAC ACA GACAGT GC – 3’, and antisense
5’– GAG GTG ATG TCC AGG AAG AA – 3’; β-actin (as an internal
standard), sense 5’– ATC TGG CAC CAC ACC TTC TA’, and antisense
5’– CTCCTTAAT GTC ACG CAC GA – 3’. Ampliﬁcation was carried
out using the Biometra PCR System (Goettingen, Germany) asfollows: polymerase chain reaction mixture was incubated at 951C
for 5 minutes, followed by 28 cycles at 941C for 30 seconds, 581C
for 30 seconds, and 721C for 1 minute, with a ﬁnal extension at
721C for 10 minutes. Then aliquots were run on 2% agarose gels
containing ethidiumn bromide. The density of the bands photo-
graphed under ultraviolet illumination was analyzed by computer
with Gel-Pro Analyzer 4.0 (Media Cybernetics Co., Rockville, MD).
The corrected relative value for the gene was expressed as a ratio
of P-selectin to β-actin.
Western blot for P-selectin protein expression
Thirty micrograms protein from kidney were denatured in
boiling water for 15 minutes, separated by SDS-PAGE gel and then
transferred onto nitrocellulose membranes. The blots were blocked
with 5% nonfat dry milk, followed by incubation for 1 hour with
rabbit anti-P-selectin at a dilution of 1:200. After being washed
with Tris-buffered saline with Tween, the blots were then incu-
bated with horseradish peroxidase conjugated secondary antibody
(1:2000 dilution) for 1 hour. The membranes were visualized with
an enhanced chemiluminescent system (KPL, Gaithersburg, MD)
after 3 washes using Tris-buffered saline with Tween.
Histopathologic examination
The right kidney was isolated immediately after sacriﬁcing each
animal and washed with ice-cold saline. It was then ﬁxed in a 10%
neutral buffered formalin solution, embedded in parafﬁn, and used
for histopathologic examination. Three- micrometers-thick sec-
tions were cut, deparafﬁnized, hydrated, and stained with periodic
acid-Schiff. The renal sections were examined in a blinded fashion
by pathologists in our hospital.
Statistical analysis
All data were presented as means [SD]. Comparisons were
performed using a 1-way ANOVA, followed when appropriate by
between-group comparisons using the Student-Neuman-Keuls multi-
ple comparison test. P o 0.05 was considered statistically signiﬁcant.Results
The results of laboratory determinations
To examine if dietary supplementation of UA attenuates renal
injury in diabetic rats, we fed STZ-treated rats a diet supplemented
with 0.2% UA for16 weeks. Comparing with untreated diabetic rats,
UA treatment lowered blood glucose levels and resulted in a
decrease in plasma lipid proﬁles to different extents, although
these levels were still higher than those in the normal control
C D D+UA
Figure 1. Renal renal 8-hydroxy-2’-deoxyguanosine level in rats of each group. Ursolic acid (UA) treatment showed signiﬁcantly reduced 8-hydroxy-2’-deoxyguanosine
formation both in glomerular and in tubulointerstitial area. C ¼ normal kidney sections; D ¼ kidney sections of untreated diabetic rat; DþUA ¼ kidney sections of UA-
treated diabetic rat.
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excretion in untreated diabetic rats was signiﬁcantly elevated and
UA therapy dramatically decreased urine albumin excretion in
diabetic rats. The serum creatinine and blood urea nitrogen
concentrations did not differ signiﬁcantly throughout the exper-
imental period among three groups. (Table)
Effect of UA on oxidative DNA injury in kidneys of diabetic rats
To examine if dietary UA affect oxidative stress in kidneys of
diabetic rats, we detected renal 8-OHdG level. Immunohistochem-
istry analysis revealed that rats receiving dietary UA showed
signiﬁcantly reduced 8-OHdG formation both in glomerular and
in tubulointerstitial area, as shown in Figure 1.
Effect of UA on NF-κB activity and P-selectin expression in kidneys of
diabetic rats
As shown in Figure 2, renal NF-κB activity in untreated diabetic
rats was signiﬁcantly increased compared with the control group,
UA administration resulted in a signiﬁcant decrease in renal NF-κB
activity after 16 weeks of therapy. Because NF-κB played a key role
in the regulation of transcription and the expression of many
inﬂammatory factors, the decrease in renal NF-κB activity would
be accompanied by a reduction of inﬂammatory factors expres-
sion. Therefore, we examined if dietary UA affects P-selectin
expression. As shown in Figure 3, UA supplementation resulted
in a reduction of P-selectin mRNA and protein expression. InC D D+UA
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Figure 2. The nuclear factor-κB (NF-κB) activity of rat kidneys in each group. Ursolic acid
weeks of the therapy compared with untreated diabetic rats. C ¼ normal control group;
result of quantitative analysis.summary, UA protected diabetic rats against the development of
kidney lesions, possibly by inhibiting NF-κB activation and then
decreasing inﬂammation factor expression.
Effect of UA on renal pathologic morphology
Examined under a microscope, the structure of glomerulus and
tubulointerstitium in kidney sections from the control rats
appeared in order. In contrast, the glomerular and tubular volume
from the diabetes group was increased, with diffuse matrix
expansion. The periodic acid-Schiff-positive area within glomeruli
was noticeably augmented. Treatment with UA showed the ability
to lower the increase in glomerular volume and the periodic acid-
Schiff-positive area seen in the rats with diabetes (Figure 4).Discussion
In our study, we examined if dietary supplementation with UA
protects kidney injury associated with diabetes. We show that UA
has the ability to protect the kidneys in rats with diabetes by
lowering urine albumin excretion and returning renal tissue
impairment. It is not possible that glucose lowering or lipid
lowering have contributed to renal protective effect in UA-
treated diabetic rats because neither blood glucose level nor blood
lipid level was reduced signiﬁcantly by UA treatment. Instead, our
data suggest anti-inﬂammation may be explained for the renal
protection in diabetes by dietary supplementation with UA.D D+UAC
(UA) administration resulted in a signiﬁcant decrease in renal NF-κB activity after 16
D ¼ diabetic group; DþUA ¼ UA-treated diabetic group. (A) Source image. (B) The
C D D+UA
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Figure 3. (A) P-selectin mRNA expression of rat kidney in each group. (B) P-selectin protein expression of rat kidney in each group. Ursolic acid (UA) supplement resulted in a
reduction of P-selectin mRNA and protein expression. C ¼ normal control group; D¼ diabetic group; DþUA ¼ UA-treated diabetic group.
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ative disease. However, more recent reports have suggested that
inﬂammation may underlie disease progression in DN. The activa-
tion of NF-κB-linked regulatory pathways generally underlies
inﬂammatory processes, and an increase in the nuclear trans-
location of NF-κB has been demonstrated in human DN.10 Studies
show that in the diabetic state, many factors, such as advanced
glycation end products, shear stress, and oxidative stress, contribute
to NF-κB activation.11 Activated NF-κB promotes the expression of a
number of genes involved in inﬂammation, such as cytokines and
adhesion molecules. All these products play a vital role in the
pathogenesis of renal diseases.12 Therefore, inhibition of NF-κB
activation may be beneﬁt for the treatment of DN. In our study,
we observed that UA signiﬁcantly suppressed NF-κB signaling in
kidneys of diabetic rats. The result was the same as that UA inhibits
NF-κB activation in another disease model.13 This ﬁnding suggests
that UA might be useful in the prevention and inhibition of
nephrologic complication in diabetes by inhibiting NF-κB activation.
To better understand the beneﬁt of NF-κB inhibition for DN, we
investigated the expression of endothelial adhesion molecules in
the downstream pathway of NF-κB such as P-selectin in diabetic
rat kidneys. There is accumulating evidence that endothelial
adhesion molecules play a pivotal role in the genesis of diabetic
vascular complications.14,15 P-selectin, a member of adhesionC D
Figure 4. Periodic acid-Schiff-stained sections of rat kidneys ( 400): Ursolic acid (UA)
sections; D ¼ kidney sections of untreated diabetic rat; DþUA ¼ kidney sections of UAmolecular family, is a marker of platelet activation, and is also
associated with endothelial dysfunction. The elevation of
P-selectin level has been previous reported in patients with
DN.16 In our study, the expression renal P-selectin in diabetic rats
was higher than healthy control rats, and UA treatment markedly
inhibited P-selectin expression. This result further shows an anti-
inﬂammatory effect of UA.
Growing evidence indicates that oxidative stress is a critical
pathologic state that leads to most of the complications seen in
diabetes. We and others have reported that increased generation
of reactive oxygen species and decreased activities of key antiox-
idant enzymes resulting in oxidative stress in kidneys of rats with
STZ-induced diabetes. Here, we observed the inﬂuence of UA on
the renal oxidative stress state in diabetes. The results showed that
UA treatment decreased oxidative injury in the kidneys of diabetic
rats, indicating the antioxidant effect of UA.Conclusions
Treatment with UA in rats with STZ-induced diabetes brought
about signiﬁcantly lowered urine albumin excretion and improved
kidney tissue injury. We have shown that UA treatment inhibits
NF-κB activation and decreases the expression of P-selectin in theD+UA
treatment improved renal histopathologic changes in diabetes. C ¼ normal kidney
-treated diabetic rat.
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effects. These ﬁndings suggest the renal protective effect of UA by
anti-inﬂammation.Acknowledgments
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